Located in Washington, D.C., B&C is a law firm focusing on conventional, biobased, and nanoscale industrial, agricultural, and specialty chemical product regulation and approval matters, including Toxic Substances Control Act (TSCA) matters, Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)/Food Quality Protection Act (FQPA) matters, U.S. Food and Drug Administration (FDA) medical device and product approval, registration and data compensation arbitrations, chemical product litigation, and associated business counseling and litigation issues. B&C's clients are involved in many businesses, including basic, specialty, and agricultural and antimicrobial chemicals; biotechnology, nanotechnology, and emerging transformative technologies; medical devices and diagnostic products; paints and coatings; plastic products; and chemical manufacturing, formulation, distribution, and consumer product sectors. Additional information is available at www.lawbc.com. B&C's affiliate B&C^® Consortia Management, L.L.C. helps the chemical industry leverage resources and maximize impact by forming consortia to achieve shared research, testing, regulatory, and access goals. The Acta Group (Acta®), B&C's scientific and regulatory consulting arm, assists chemical and product manufacturers in marketing and sustaining their products globally.